Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CVS Expands Formulary Exclusions In 2017, Express Scripts’ Tally Unchanged

Executive Summary

National formulary exclusions continue in 2017, with CVS aggressively expanding its list of “not covered” drugs. Express Scripts currently excludes slightly fewer drugs than last year but may still add to its list.

You may also be interested in...



Bristol/Pfizer's Eliquis Better For Preventing Strokes And Bleeding In Large Real-World Trial

In Bristol/Pfizer's ARISTOPHANES real-world study, the rate of major bleeding with Eliquis was 46% lower than J&J/Bayer's Xarelto and 33% lower than Boehringer's Pradaxa.

CVS 2018 Formulary: Outcomes-Based Contracts In Oncology, Obesity, COPD

And for diabetes, Jardiance is out and Invokana is in; CVS formulary update includes far fewer exclusions than previous years and reinstates coverage for several drugs, signaling more muted approach to management.

Express Scripts Boosts Formulary Exclusions With Focus On Multi-Source Brands

Pharmacy benefit manager adds 64 drugs to its list of formulary exclusions for 2018, bringing to 159 the number designated as not covered.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS118897

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel